BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu C, Pelech S, Zhang H, Bond J, Spach K, Noubade R, Blankenhorn EP, Teuscher C. Pertussis toxin induces angiogenesis in brain microvascular endothelial cells. J Neurosci Res 2008;86:2624-40. [PMID: 18500752 DOI: 10.1002/jnr.21716] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Howland SW, Poh CM, Rénia L. Activated Brain Endothelial Cells Cross-Present Malaria Antigen. PLoS Pathog 2015;11:e1004963. [PMID: 26046849 DOI: 10.1371/journal.ppat.1004963] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 9.7] [Reference Citation Analysis]
2 Kilic AK, Esendagli G, Sayat G, Talim B, Karabudak R, Kurne AT. Promotion of experimental autoimmune encephalomyelitis upon neutrophil granulocytes’ stimulation with formyl-methionyl-leucyl-phenylalanine (fMLP) peptide. Autoimmunity 2015;48:423-8. [DOI: 10.3109/08916934.2015.1030615] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
3 Collongues N, Chanson JB, Blanc F, Steibel J, Lam CD, Shabbir A, Trifilieff E, Honnorat J, Pham-Dinh D, Ghandour MS, de Seze J. The Brown Norway opticospinal model of demyelination: does it mimic multiple sclerosis or neuromyelitis optica? Int J Dev Neurosci 2012;30:487-97. [PMID: 22634288 DOI: 10.1016/j.ijdevneu.2012.05.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lu C, Diehl SA, Noubade R, Ledoux J, Nelson MT, Spach K, Zachary JF, Blankenhorn EP, Teuscher C. Endothelial histamine H1 receptor signaling reduces blood-brain barrier permeability and susceptibility to autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2010;107:18967-72. [PMID: 20956310 DOI: 10.1073/pnas.1008816107] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
5 Sanabria-Castro A, Flores-Díaz M, Alape-Girón A. Biological models in multiple sclerosis. J Neurosci Res 2020;98:491-508. [PMID: 31571267 DOI: 10.1002/jnr.24528] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
6 Gupta NC, Davis CM, Nelson JW, Young JM, Alkayed NJ. Soluble epoxide hydrolase: sex differences and role in endothelial cell survival. Arterioscler Thromb Vasc Biol 2012;32:1936-42. [PMID: 22723436 DOI: 10.1161/ATVBAHA.112.251520] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
7 Krementsov DN, Wall EH, Martin RA, Subramanian M, Noubade R, Del Rio R, Mawe GM, Bond JP, Poynter ME, Blankenhorn EP, Teuscher C. Histamine H(3) receptor integrates peripheral inflammatory signals in the neurogenic control of immune responses and autoimmune disease susceptibility. PLoS One 2013;8:e62743. [PMID: 23894272 DOI: 10.1371/journal.pone.0062743] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
8 Montagne A, Zhao Z, Zlokovic BV. Alzheimer's disease: A matter of blood-brain barrier dysfunction? J Exp Med 2017;214:3151-69. [PMID: 29061693 DOI: 10.1084/jem.20171406] [Cited by in Crossref: 240] [Cited by in F6Publishing: 229] [Article Influence: 60.0] [Reference Citation Analysis]
9 Pottiez G, Flahaut C, Cecchelli R, Karamanos Y. Understanding the blood-brain barrier using gene and protein expression profiling technologies. Brain Res Rev 2009;62:83-98. [PMID: 19770003 DOI: 10.1016/j.brainresrev.2009.09.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
10 Sotnikov I, Veremeyko T, Starossom SC, Barteneva N, Weiner HL, Ponomarev ED. Platelets recognize brain-specific glycolipid structures, respond to neurovascular damage and promote neuroinflammation. PLoS One 2013;8:e58979. [PMID: 23555611 DOI: 10.1371/journal.pone.0058979] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
11 Das A, Guyton MK, Smith A, Wallace G 4th, McDowell ML, Matzelle DD, Ray SK, Banik NL. Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats. J Neurochem 2013;124:133-46. [PMID: 23106593 DOI: 10.1111/jnc.12064] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 4.7] [Reference Citation Analysis]
12 Roscoe WA, Welsh ME, Carter DE, Karlik SJ. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE. J Neuroimmunol 2009;209:6-15. [PMID: 19233483 DOI: 10.1016/j.jneuroim.2009.01.009] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 4.9] [Reference Citation Analysis]
13 Bhaskar S, Tian F, Stoeger T, Kreyling W, de la Fuente JM, Grazú V, Borm P, Estrada G, Ntziachristos V, Razansky D. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Part Fibre Toxicol 2010;7:3. [PMID: 20199661 DOI: 10.1186/1743-8977-7-3] [Cited by in Crossref: 270] [Cited by in F6Publishing: 230] [Article Influence: 24.5] [Reference Citation Analysis]
14 Vézina A, Charfi C, Zgheib A, Annabi B. Cerebrovascular Angiogenic Reprogramming upon LRP1 Repression: Impact on Sphingosine-1-Phosphate-Mediated Signaling in Brain Endothelial Cell Chemotactism. Mol Neurobiol 2018;55:3551-63. [DOI: 10.1007/s12035-017-0614-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
15 Kanwar JR, Sun X, Punj V, Sriramoju B, Mohan RR, Zhou SF, Chauhan A, Kanwar RK. Nanoparticles in the treatment and diagnosis of neurological disorders: untamed dragon with fire power to heal. Nanomedicine 2012;8:399-414. [PMID: 21889479 DOI: 10.1016/j.nano.2011.08.006] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 7.7] [Reference Citation Analysis]
16 Dang PT, Bui Q, D’souza CS, Orian JM. Modelling MS: Chronic-Relapsing EAE in the NOD/Lt Mouse Strain. In: La Flamme AC, Orian JM, editors. Emerging and Evolving Topics in Multiple Sclerosis Pathogenesis and Treatments. Cham: Springer International Publishing; 2015. pp. 143-77. [DOI: 10.1007/7854_2015_378] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
17 Howland SW, Gun SY, Claser C, Poh CM, Rénia L. Measuring antigen presentation in mouse brain endothelial cells ex vivo and in vitro. Nat Protoc 2015;10:2016-26. [PMID: 26562622 DOI: 10.1038/nprot.2015.129] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
18 Fernandez-Cadenas I, Mendioroz M, Domingues-Montanari S, Del Rio-Espinola A, Delgado P, Ruiz A, Hernandez-Guillamon M, Giralt D, Chacon P, Navarro-Sobrino M, Ribo M, Molina CA, Alvarez-Sabin J, Rosell A, Montaner J. Leukoaraiosis is associated with genes regulating blood-brain barrier homeostasis in ischaemic stroke patients. Eur J Neurol 2011;18:826-35. [PMID: 21122033 DOI: 10.1111/j.1468-1331.2010.03243.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
19 deLuca LE, Pikor NB, O'Leary J, Galicia-Rosas G, Ward LA, Defreitas D, Finlay TM, Ousman SS, Osborne LR, Gommerman JL. Substrain differences reveal novel disease-modifying gene candidates that alter the clinical course of a rodent model of multiple sclerosis. J Immunol 2010;184:3174-85. [PMID: 20173032 DOI: 10.4049/jimmunol.0902881] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
20 Towner RA, Smith N, Zalles M, Morris S, Toliver M, Saunders D, Lerner M, Kumar G, Axtell RC. ELTD1 as a biomarker for multiple sclerosis: Pre-clinical molecular-targeted studies in a mouse experimental autoimmune encephalomyelitis model. Mult Scler Relat Disord 2021;49:102786. [PMID: 33517175 DOI: 10.1016/j.msard.2021.102786] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 D'Auria KM, Donato GM, Gray MC, Kolling GL, Warren CA, Cave LM, Solga MD, Lannigan JA, Papin JA, Hewlett EL. Systems analysis of the transcriptional response of human ileocecal epithelial cells to Clostridium difficile toxins and effects on cell cycle control. BMC Syst Biol 2012;6:2. [PMID: 22225989 DOI: 10.1186/1752-0509-6-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
22 Heidari AR, Boroumand-Noughabi S, Nosratabadi R, Lavi Arab F, Tabasi N, Rastin M, Mahmoudi M. Acylated and deacylated quillaja saponin-21 adjuvants have opposite roles when utilized for immunization of C57BL/6 mice model with MOG35-55 peptide. Mult Scler Relat Disord 2019;29:68-82. [PMID: 30685444 DOI: 10.1016/j.msard.2019.01.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
23 Diehl SA, McElvany B, Noubade R, Seeberger N, Harding B, Spach K, Teuscher C. G proteins Gαi1/3 are critical targets for Bordetella pertussis toxin-induced vasoactive amine sensitization. Infect Immun 2014;82:773-82. [PMID: 24478091 DOI: 10.1128/IAI.00971-13] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
24 Lassmann H, Bradl M. Multiple sclerosis: experimental models and reality. Acta Neuropathol 2017;133:223-44. [PMID: 27766432 DOI: 10.1007/s00401-016-1631-4] [Cited by in Crossref: 212] [Cited by in F6Publishing: 204] [Article Influence: 42.4] [Reference Citation Analysis]
25 Tang Z, Yin JX, Han P, Gan Y, Coons SW, Wang C, Maalouf M, Shi J. Pertussis toxin attenuates experimental autoimmune encephalomyelitis by upregulating neuronal vascular endothelial growth factor. Neuroreport 2013;24:469-75. [PMID: 23660634 DOI: 10.1097/WNR.0b013e3283619fc8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
26 Lindgren HS, Ohlin KE, Cenci MA. Differential Involvement of D1 and D2 Dopamine Receptors in L-DOPA-Induced Angiogenic Activity in a Rat Model of Parkinson's Disease. Neuropsychopharmacol 2009;34:2477-88. [DOI: 10.1038/npp.2009.74] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 5.0] [Reference Citation Analysis]